Bosutinib M14314
The add to cart button will appear once you select the values above
Specifications
| inquiry |
CAS Number:
380843-75-4
Target:
Bcr-Abl
Molecular formula:
C26H29Cl2N5O3
Formula weight:
530,45
Purity:
>98%(HPLC)
Stability:
≥ 2 years
Product description:
Bosutinib is a Bcr-Abl kinase inhibitor for the treatment of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML).
Note:
Research use only, not for human use.
More info:
Email info@sobekbio.com
Orders:
Email orders@sobekbio.com